The Medtech industry is in one of its most exciting times in history – we call this Convergence.
The convergence of advanced materials science, component miniaturization, sensors and software, telecommunications and new delivery models is creating the potential for new and disruptive solutions for many of the most significant and costly health challenges. The prospect of investing to transform the healthcare industry becomes the goal of the Medtech Convergence Fund.
The future of medtech resides in the shifts from intervention to prevention, invasive to non-invasive and hospitals to the home. We are focused on technologies that can expand patient access via telehealth or utilize monitoring technologies to otherwise extend more effective management of chronic disease to the least intensive setting and ultimately the home.
Our portfolio companies will help reduce the increasing burden on clinicians and drive down healthcare operating costs. As a leader in early-stage medical device innovation, we expect our entrepreneurs, our investments and our portfolio companies will define new therapies and create new care settings.